TY - JOUR
T1 - Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents
AU - Araki, Hiroto
AU - Mahmud, Nadim
AU - Milhem, Mohammed
AU - Nunez, Rafael
AU - Xu, Mingjiang
AU - Beam, Craig A.
AU - Hoffman, Ronald
PY - 2006/2
Y1 - 2006/2
N2 - Objective. We investigated whether the addition of two chromatin-modifying agents, 5-aza-2′-deoxycytidine (5azaD) and trichostatin A (TSA), to cord blood (CB) CD34+ cells in culture results in expansion of the numbers of severe combined immunodeficient (SCID) repopulating cells (SRC). Materials and Methods. Human CB CD34+ cells were cultured with cytokines in the presence or absence of 5azaD/TSA. After 9 days of culture, the fold expansion of CD34+ and CD34+CD90+ cell numbers, colony-forming unit (CFU)-mix, cobblestone area-forming cell (CAFC), and SRC numbers were determined. Results. A 12.5-fold expansion of CD34 +CD90+ cells was observed in the 5azaD/TSA-treated cultures in comparison to the input cell numbers. Expansion of CD34 +CD90+ cells was associated with a 9.8-fold increase in the numbers of CFU-mix and 11.5-fold increase in CAFC. 5azaD/TSA treatment of the CB CD34+ cells resulted in a 9.6-fold expansion of the absolute number of SRC following 9 days of culture as determined by limiting dilution analysis. Expansion of cells maintaining CD34+CD90+ phenotype was not due to the retention of a quiescent population of cells because all of the CD34+CD90+ cells in the culture had undergone cellular division. 5azaD/TSA-treated CD34+CD90+ cells, but not CD34+CD90- cells were responsible for in vivo hematopoietic repopulation potential of nonobese diabetic/SCID mice. Conclusion. Ex vivo expansion strategy using chromatin-modifying agents provides a potential avenue by which to expand the number of hematopoietic stem cells (HSC) with a single CB unit for use as an alternative source of HSC grafts for adult recipients.
AB - Objective. We investigated whether the addition of two chromatin-modifying agents, 5-aza-2′-deoxycytidine (5azaD) and trichostatin A (TSA), to cord blood (CB) CD34+ cells in culture results in expansion of the numbers of severe combined immunodeficient (SCID) repopulating cells (SRC). Materials and Methods. Human CB CD34+ cells were cultured with cytokines in the presence or absence of 5azaD/TSA. After 9 days of culture, the fold expansion of CD34+ and CD34+CD90+ cell numbers, colony-forming unit (CFU)-mix, cobblestone area-forming cell (CAFC), and SRC numbers were determined. Results. A 12.5-fold expansion of CD34 +CD90+ cells was observed in the 5azaD/TSA-treated cultures in comparison to the input cell numbers. Expansion of CD34 +CD90+ cells was associated with a 9.8-fold increase in the numbers of CFU-mix and 11.5-fold increase in CAFC. 5azaD/TSA treatment of the CB CD34+ cells resulted in a 9.6-fold expansion of the absolute number of SRC following 9 days of culture as determined by limiting dilution analysis. Expansion of cells maintaining CD34+CD90+ phenotype was not due to the retention of a quiescent population of cells because all of the CD34+CD90+ cells in the culture had undergone cellular division. 5azaD/TSA-treated CD34+CD90+ cells, but not CD34+CD90- cells were responsible for in vivo hematopoietic repopulation potential of nonobese diabetic/SCID mice. Conclusion. Ex vivo expansion strategy using chromatin-modifying agents provides a potential avenue by which to expand the number of hematopoietic stem cells (HSC) with a single CB unit for use as an alternative source of HSC grafts for adult recipients.
UR - http://www.scopus.com/inward/record.url?scp=31844449339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31844449339&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2005.10.002
DO - 10.1016/j.exphem.2005.10.002
M3 - Article
C2 - 16459182
AN - SCOPUS:31844449339
VL - 34
SP - 140
EP - 149
JO - Experimental Hematology
JF - Experimental Hematology
SN - 0301-472X
IS - 2
ER -